News: Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
08/15Inozyme Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Quipt Home Medical Announces Commitment Letter for $80 Million of Senior Credit Facilities to Fund Future Growth
CI
08/15Vivos Therapeutics, Inc. Announces Delay in the Release of its Financial Results for the Second Quarter Ended June 30, 2022
CI
08/15Auxly Cannabis Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Roivant Sciences Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
08/15Bioxytran, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Medicenna Therapeutics Corp. Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
08/15LogicBio Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Viridian Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Gracell Biotechnologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Pyxis Oncology, Inc. Appoints Rachel Humphrey to Its Board of Directors
CI
08/15Saintmed Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15ATAI Life Sciences N.V. and ATAI Life Sciences AG Enter into Loan and Security Agreement with Hercules Capital, Inc
CI
08/15Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/159 Meters Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Discover
08/15Brainstorm Cell Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Virios Therapeutics, Inc. Announces Dosing of First Patient in IMC-2 Long-COVID Treatment Trial
CI
08/15Brainstorm Cell Therapeutics Inc. Submits Biologics License Application to the U.S. Food and Drug Administration for NurOwn for the Treatment of Amyotrophic Lateral Sclerosis
CI
08/15Willow Biosciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Clene Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15MediPharm Labs Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Gelesis Holdings, Inc. Provides Revenue Guidance for the Full Year 2022
CI
08/15Arvinas, Inc. Appoints Lisa Sinclair as Senior Vice President, Corporate Operations
CI
08/15ALX Oncology Holdings Inc. and Quantum Leap Healthcare Collaborative Announces the Selection of Evorpacept in the I-SPY-P1 Trial in Combination with Enhertu® in Breast Cancer
CI
08/15BeiGene Announces Strategic Alliance with Ontada to Improve U.S. Community Oncology Care
CI
08/15Genprex Announces Safety Review Committee Approves Dose Escalation in Acclaim-1 Phase 1/2 Trial of REQORSA™ in Combination with Tagrisso® in Non-Small Cell Lung Cancer
CI
08/15Clene Reports Positive Topline Results for CNM-Au8® in the Phase 2 VISIONARY-MS Trial in Multiple Sclerosis
CI
08/15Alaunos Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2022
CI
08/15Organogenesis Receives FDA Clearance for Next Generation PuraPly Surgical Solution
CI
08/15Roivant Sciences Ltd. Appoints Amy Mahery as Chief Commercial Officer
CI
08/15Gelesis Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Akouos, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15SCYNEXIS, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2022
CI
08/15Pyxis Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Plus Therapeutics, Inc. announces an Equity Buyback for $2 million worth of its shares.
CI
08/15Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022
CI
08/15Viridian Therapeutics, Inc. Announces Positive Initial Clinical Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Thyroid Eye Disease
CI
08/15Hbm Holdings Limited Announces Change of Address of Principal Place of Business in Hong Kong
CI
08/15BD, Accelerate Diagnostics Announces Global Commercial Collaboration
CI
08/15TherapeuticsMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Variant-adapted COVID vaccine wins first approval in Britain
RE
08/15TOT BIOPHARM International Company Limited Announces Change of Address of Registered Office
CI
08/15Adial Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Nymox Pharmaceutical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15DarioHealth Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Embecta Corp. Revises Revenue Guidance for the Second-Half Fiscal Year 2022
CI
08/15Ainos, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Guangdong Hybribio Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/15Sigyn Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15QSAM Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15BioQuest Corp. Reports Earnings Results for the Full Year Ended April 30, 2022
CI
08/15Lee's Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2022
CI
08/15Eliem Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15UK Approves Moderna's Omicron-Containing Covid-19 Booster Vaccine
DJ
08/15IDEAYA Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Rubicon Organics Inc. Announces Resignation of Bryan Disher from the Board of Directors
CI
08/15Embecta Corp. Announces Inaugural Quarterly Cash Dividend, Payable on September 14, 2022
CI
08/15BD, Accelerate to Collaborate on Testing-Kit Distribution
DJ
08/15FTSE 100 ends higher as AstraZeneca offsets commodity losses
RE
08/15Shanghai Henlius Biotech, Inc. Announces the First Patient Has Been Dosed in A Phase 1 Clinical Trial of HLX26
CI
08/15TRANSCRIPT : Qatari German Company for Medical Devices (Q.P.S.C.), Q2 2022 Earnings Call, Aug 15, 2022
CI
08/15Yonghe Medical Group Co., Ltd. Announces Change of Address of Principal Place of Business in Hong Kong
CI
08/15Shanghai Henlius Biotech, Inc. Announces Acceptance of Supplemental New Drug Application of HANBEITAI (Bevacizumab Injection)
CI
08/15Frontage Holdings Corporation Announces Change of Address of Principal Place of Business in Hong Kong
CI
Discover
08/15European shares edge higher on defensive lift, weak China data stokes worries
RE
08/15Bayer Launches ForGround
CI
08/15Lepu Biopharma Co., Ltd. Change of Address of Principal Place of Business in Hong Kong
CI
08/15Hang Chi Holdings Limited Announces Executive Changes
CI
08/15Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Prev.1  2  3  4   5  6  7  8  9  10Next